ACCO exhibits weak financial health with a Piotroski F-Score of 4/9, indicating marginal stability, and lacks an Altman Z-Score, raising concerns about bankruptcy risk assessment. Despite a low valuation as reflected by a Price/Book of 0.55 and a Graham Number of $8.12—well above the current price of $3.93—the company faces declining fundamentals, including negative revenue and earnings growth. Profitability metrics are below sector averages, with shrinking margins and weak ROE, while the high dividend yield of 7.43% appears unsustainable given the 71.43% payout ratio and deteriorating cash flows. Although the stock is cheap on a valuation basis, structural operational weaknesses and bearish technical trends suggest significant downside risks.